In a first, the U.S. FDA accepted an artificial intelligence (AI)/machine learning-model into its Innovative Science and Technology Approaches for New Drugs (ISTAND) pilot program for drug development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results